By contrast, anti-centromere antibodies (ACAs) and anti-topoisomerase I antibodies (ATAs) do not show a consistent association with specific cancer types, although ATA positivity is clinically relevant due to its association with severe ILD, which may indirectly raise lung cancer risk [49]. Here, ATM is linked to cancer.